Business & Industry

The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based biotechnology firm and the deal was indeed a result of a heated bidding battle against...

European venture capital firm Sofinnova Partners said on November 17 that it raised 650 million euros, equivalent to $750 million, for a new fund that is going to support the present and upcoming life sciences companies. It is well to be...

Johnson & Johnson will be paying $3.05 billion so as to acquire Halda Therapeutics, thereby getting a novel cell death platform while at the same time also strengthening its prostate cancer franchise that’s built on Erleada. At the mainstay of the...

An analysis by BCC Research shows that the market for analytical laboratory instruments will grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028, rising from $60.9 billion in 2023 to $82.5 billion by 2028. The...

The pharmaceutical industry is undergoing a profound transformation in how it approaches pricing decisions, market access negotiations, and tender participation through the strategic deployment of artificial intelligence technologies. AI in pharma market access represents a paradigm shift from traditional...

The Food and Drug Administration is looking to speed the development when it comes to biosimilars and has announced new guidelines, which would no longer want the makers of copycat biologics to indulge in human trials, therefore showing that...

In just a space of 24 hours, GSK, in its second pipeline-expanding deal, has gone on to license the rights to a drug for chronic obstructive pulmonary disease – COPD from Empirico, the US biotech, for $85 million, and...